We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Drugs: User Fee Programs Top Industry’s Concerns in 2012
Generic Drugs: User Fee Programs Top Industry’s Concerns in 2012
January 12, 2012
All eyes of the generic drug industry will be focused on Capitol Hill this year as Congress readies for action on the proposed Generic Drug User Fee Act (GDUFA) after years of FDA and industry efforts on the agreement.